HeteroSight raises CHF 100,000

HeteroSight, which stems from CHUV, is developing an AI tool that reveals on a standard biopsy slide whether a tumour contains several genetically distinct zones. The project has received a FIT-InnoTREK grant of CHF 100,000 to build a first cohort and validate its model.

Announced on
Round
Grant
Amount
CHF 100,000
Sector
Health & medtech

Investors

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic